Intrust Bank’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,358
Closed -$327K 374
2018
Q3
$327K Sell
6,358
-2,679
-30% -$134K 0.08% 279
2018
Q2
$455K Sell
9,037
-1,369
-13% -$69.4K 0.13% 208
2018
Q1
$531K Sell
10,406
-2,169
-17% -$116K 0.15% 173
2017
Q4
$661K Sell
12,575
-4,290
-25% -$213K 0.2% 142
2017
Q3
$825K Buy
16,865
+2,934
+21% +$140K 0.27% 105
2017
Q2
$674K Buy
13,931
+712
+5% +$32.8K 0.23% 125
2017
Q1
$557K Buy
13,219
+99
+0.8% +$4.09K 0.2% 147
2016
Q4
$553K Buy
13,120
+7
+0.1% +$286 0.21% 146
2016
Q3
$574K Buy
13,113
+277
+2% +$12.4K 0.23% 137
2016
Q2
$559K Buy
12,836
+1,440
+13% +$62.1K 0.23% 142
2016
Q1
$502K Buy
+11,396
New +$483K 0.18% 162

Other funds holding FMS

Intrust Bank's FMS Position: Q4 2018 in Review

Intrust Bank sold out of Fresenius Medical Care (FMS) in Q4 2018, closing a stake of 6,358 shares — an estimated $327K sold.

Intrust Bank first reported a position in FMS in Q1 2016 and held it in 11 quarters. The position peaked at $825K in Q3 2017. 197 funds tracked by Wall St. Rank hold FMS as of Q4 2018.

  • Intrust Bank reported no remaining Fresenius Medical Care position as of Q4 2018 after selling out during the quarter.
  • Intrust Bank sold 6,358 Fresenius Medical Care shares in Q4 2018, an estimated $327K.
  • Intrust Bank first reported a position in Fresenius Medical Care in Q1 2016 and held it in 11 quarters.
  • Intrust Bank's Fresenius Medical Care position peaked at $825K in Q3 2017.
  • 197 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2018.

Based on Intrust Bank's 13F filing for Q4 2018, filed 6 Feb 2019.